Tools
Register Login

biolyon.com

You are here: Home » press
Friday, 15 Dec 2017

Industry Releases

MdBio Foundation and Tech Council of Maryland Host ATLAS STEM Career Symposium for Underrepresented Students at the University of Baltimore

--(BUSINESS WIRE)--MdBio Foundation hosts ATLAS – a career symposium for high school juniors, seniors and college undergrads typically underrepresented in Science STEM fields.

Truven Health Analytics and the Johns Hopkins Bloomberg School of Public Health Collaborate to Launch Institute for Health and Productivity Studies

BALTIMORE--(BUSINESS WIRE)--Truven Health Analytics and the Johns Hopkins Bloomberg School of Public Health Collaborate to Launch Institute for Health and Productivity Studies

SpeechVive Completes Funding to Move Speech Aid for Parkinsons Patients to the Public

LAFAYETTE, Ind. & FORT WAYNE, Ind.--(BUSINESS WIRE)--SpeechVive Inc. will launch U.S. sales of a device that reduces speech impairments associated with Parkinson's disease. It received nearly $700,000 in funding from Indiana-based Ambassador Ventures.

FIRST® Announces Qualcomm as the Presenting Championship Sponsor along with Expanding List of Sponsors for 2014 FIRST Championship Event

MANCHESTER, N.H.--(BUSINESS WIRE)--FIRST® Announces Qualcomm as the Presenting Championship Sponsor along with Expanding List of Sponsors for 2014 FIRST Championship Event

Commercial Building Energy Efficiency Retrofits Will Surpass 127 Billion in Annual Market Value by 2023 Forecasts Navigant Research

BOULDER, Colo.--(BUSINESS WIRE)--The worldwide market for energy efficiency retrofits in commercial and public buildings will grow from $68.2 billion in 2014 to $127.5 billion by 2023, forecasts Navigant Research.

Samenvatting Novaliq GmbH start Fase 1-onderzoek naar behandeling met CyclASol®

HEIDELBERG, Germany--(BUSINESS WIRE)--Novaliq GmbH heeft vandaag bekendgemaakt dat het is begonnen met een fase 1-onderzoek naar CyclASol (Cyclosporinoplossing). Dit is een reactie op de recente Amerikaanse en Europese goedkeuring van het patent op de oplossing voor de behandeling van het droge ogensyndroom. Conventionele formules van cyclosporin zijn emulsies. CyclASol de het eerste en enige cyclosporingoplossing. CyclASol is verkrijgbaar in multi-doses en in conserveermiddelvrije flessen voor

First Patients Implanted with ICDs in BIOTRONIK ProMRI® Study

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that the first patients across the United States have received implants of the new Iforia implantable cardioverter-defibrillators (ICDs). Implants occurred soon after BIOTRONIK received Food and Drug Administration (FDA) approval for the new phase of its ongoing ProMRI® trial. Phase C will investigate the safety of ICDs in the MRI environment. The first U.S. clinical study

Novaliq GmbH annonce le lancement d’une étude de phase 1 suite à l’approbation de brevet aux États-Unis et en Europe pour les gouttes ophtalmiques CyclASol® Ciclosporine

HEIDELBERG, en Allemagne--(BUSINESS WIRE)--Novaliq GmbH a annoncé aujourd’hui le début d’une étude de phase 1 pour CyclASol (solution de ciclosporine) suite à l’approbation de brevet aux États-Unis et en Europe pour la solution de traitement contre le syndrome de l’œil sec. Tandis que les formulations classiques à base de ciclosporine sont des émulsions, CyclASol est la première et unique solution de ciclosporine claire à 0,05 %. CyclASol est disponible en flacons à doses multiples sans conserv

Cytox Closes £15M Second Round of Funding for Alzheimer’s biomarker

MANCHESTER, United Kingdom--(BUSINESS WIRE)--Cytox Ltd, (Cytox) a leading developer of assays for risk assessment and prediction of dementia, today announced the successful completion of a second round of funding, closing at £1.5M. New shareholders include Seneca Partners Ltd. and the round was led by existing shareholder, SPARK, Northwest Fund for Biomedical with strong support from other existing shareholders including Wren Capital and The Rainbow Seed Fund (Midven), as well as private invest

LEGO® MINDSTORMS® Education EV3 Science Activity Pack Takes Robots from Fiction to Fact

BOSTON--(BUSINESS WIRE)--LEGO® Education announced today at the National Science Teachers Association national conference the LEGO MINDSTORMS® Education EV3 Science Activity Pack.

Page 1 of 102

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »